Normal BMI, But Is Your Belly Fat Putting Your Health at Risk?
Two people. Same height. Same weight. Same BMI, squarely in the "normal" range. Would you assume their health risks are the same? Think again. A new study of more than 60,000 young people across 70 countries suggests that almost one in five people with a normal BMI may carry fat where it matters, and the scale alone would never tell them.
Join Holly and Jim as they unpack what this research means for you. You'll learn why BMI is useful but doesn't tell the whole story, and how a simple measurement you can take at home might add an important clue. They also talk candidly about what you can (and can't) do with that information today. Grab a tape measure and find out why the goal isn't just a "normal" number; it's getting healthier.
Discussed on the episode:
- The two-person thought experiment that shows why the same BMI doesn't always mean the same health risk
- The surprising share of young adults the researchers found hiding in the "you're fine" category.
- A simple bit of math, using just your height and a tape measure, that you can do at home today
- The common measuring mistake that could be making your waist look smaller than it really is
- Why the answer to "should I be worried?" isn't a diagnosis, but might be a useful warning flag
- Whether a normal-weight person with a larger waist could qualify for a GLP-1 medication (the answer may not be what you expect)
- Whether you can exercise away belly fat specifically, and the good news hiding in the data
- Holly's candid answer about whether she would consider a GLP-1 herself, and Jim's reveal of his own number
- Why the scale isn't wrong, it's just answering a smaller question than we need to ask.
- The "health report card" idea: the full set of measures worth looking at together
00:37 - BMI Doesn’t Tell the Whole Story
02:08 - A Global Study Finds Hidden Central Obesity
04:19 - Understanding Waist-to-Height Ratio
08:22 - How to Measure Your Waist
11:21 - What the Study Revealed About Health Risks
13:55 - BMI and Waist: Both Matter
16:37 - Do Current Medication Guidelines Miss People?
19:16 - What to Do About a High Waist Ratio
22:58 - Could GLP-1s Be Used Beyond Weight Loss?
24:49 - Practical Steps and a Broader Health Picture
27:32 - Listener Questions: Waist, BMI, and GLP-1s
30:19 - Rapid-Fire Questions on Risk and Treatment
33:31 - A Personal Waist-to-Height Check
34:52 - The Big Takeaways: Look Beyond the Scale
James Hill:
Welcome to Weight Loss And, where we delve into the world of weight loss. I'm Jim Hill.
Holly Wyatt:
And I'm Holly Wyatt. We're both dedicated to helping you lose weight, keep it off, and live your best life while you're doing it.
James Hill:
Indeed, we now realize successful weight loss combines the science and art of medicine, knowing what to do and why you will do it.
Holly Wyatt:
Yes, the “And” allows us to talk about all the other stuff that makes your journey so much bigger, better, and exciting.
James Hill:
Ready for the “And” factor?
Holly Wyatt:
Let's dive in.
James Hill:
Here we go.
Holly Wyatt:
Jim, imagine two people. They're both 5'6", right? 5'6".
James Hill:
Okay.
Holly Wyatt:
Both weigh 145 pounds, and both of them have exactly the same BMI. I think it's around 23, 24. Would you assume they have the same health risks in terms of their body weight?
James Hill:
I think this is a trick question for me, Holly.
Holly Wyatt:
No, never.
James Hill:
So BMI would put them in the same weight category. But I think we know that BMI is not the whole story and that their health risks may not be the same, even with the same BMI.
Holly Wyatt:
Yeah. And I think what's even more important is their BMI is in the normal weight category at this point, right? BMI 23, 24.
James Hill:
Right. So, you would say not much risk at all if you just went with BMI.
Holly Wyatt:
Correct. So, now let's imagine one of them has a 29-inch waist and the other one has a 36-inch waist. Same height, same weight, same BMI. Could that difference matter?
James Hill:
Absolutely, because BMI doesn't tell us where the fat is. And where the fat is located can matter metabolically. Even with the same amount of fat, if it's in different locations, it can have different risk.
Holly Wyatt:
Yeah, and that's what got my attention. There's a study that we're going to talk about on this podcast that came out, and researchers looked at more than 60,000 young people across 70 countries, Jim.
James Hill:
A large number.
Holly Wyatt:
Large number young people, which is, I think, going to be interesting for us. And nearly one in five, almost around 20%, had a normal BMI but also had what researchers are calling central obesity.
James Hill:
So this suggests that you can have a normal BMI and still have too much belly fat.
Holly Wyatt:
Yeah. And in this study, the group had a higher odds of having high cholesterol, high blood pressure, diabetes. And these are people who are 15 to 29 years old, Jim.
James Hill:
That's pretty young. Maybe we should consider what we're missing when we judge health just by weight alone.
Holly Wyatt:
And here's another question. If your BMI is normal, but your waist measurement, your waist circumference suggests the problem, maybe is elevated, what should you actually do about it? Could that ever include a weight loss medication?
James Hill:
All right, Holly, I'm seeing a pattern here in what we've been talking about lately, that we're separating what the scale tells us from other aspects. And in this case, separating what the scale tells us from what the waist tells us and that we may need to consider both in actually determining treatment.
Holly Wyatt:
Yes, exactly. So let's just jump right in and talk about this study and then we'll go on from there. You know, we always have lots of opinions about the studies, but at least we like to start with it. So there was a study that recently came out, I think the end of October, 2026, so pretty soon, not very long ago, and it used World Health Organization STEPS data, which are surveys, and I think these surveys were from 2010 to 2023. It was around 60,000 people ages 15 to 29 in the 70 countries, and this was cross-sectional analysis.
Holly Wyatt:
So this study looked at, they measured a lot of things, but in this case measured height, weight, waist circumference, blood pressure, fasting glucose, total cholesterol, and they calculated what they're calling central obesity, and they define this as a waist-to-height ratio greater than 0.5. Now, Jim, we talk a lot about waist. Sometimes we don't talk about it in terms of waist-to-height ratio. In the United States, we tend to use a cutoff and not use this ratio as much, so I think it's important we tell our listeners what this is about. So, in this case, a normal weight central obesity, when they talk about normal weight central obesity, it required a normal BMI, but an elevated waist to height ratio, which means greater than 0.5. So let's break that down, Jim. Let's say someone was five feet tall, which would be 60 inches. Make sure I do my math right. 60 inches. And to have a waist to height ratio greater than 0.5, they would need 30 inches. So if their waist was 30 or greater, their ratio would be greater. That's this 0.5 ratio would be greater. Let's say they were 5'6", that would be what, 66?
Holly Wyatt:
So, that'd be 66. And so, they would meet this criteria if their waist was 33 inches, or greater.
James Hill:
Right.
Holly Wyatt:
But if their waist was 30 inches, they wouldn't make this waist-to-height ratio of greater than 0.5.
James Hill:
Right.
Holly Wyatt:
That makes sense? Did I get my numbers right?
James Hill:
It is. And in this case, Holly, the waist-to-height ratio really is a proxy for central fat. They didn't measure it. We can actually measure it. We have devices to measure it, but it would be tough in this large a sample to get all those measurements by other means. So it's a proxy for central fat.
Holly Wyatt:
Yes, that's important for us to realize. So it's a pretty good proxy, though. There's not a lot of other things that kind of get in the way, but you're right. They did not measure it directly. So we're guessing that as the waist goes up, the visceral central obesity goes up. Now, in the United States, Jim, we don't use waist to height as commonly as we use individual cutoffs. And I think we talked on this show about some of the individual cutoffs.
James Hill:
We talk about just using the waist and is the waist high or not?
Holly Wyatt:
Yes. And when we do that, there's two different numbers that pop up that has a lot of research behind them. And we talk about using a cutoff of 35 inches for women and 40 inches for men.
James Hill:
Okay.
Holly Wyatt:
So instead of looking at the ratio, if you measure your waist and you're a woman and it's greater than 35, we say high risk, higher risk. We think that there's potentially too much or a large amount of fat in that central distribution. But if you're a man, 40 inches becomes a cutoff. So a little two different ways of doing it. But I think trying to kind of get at the same thing.
James Hill:
But it seems, Holly, in looking at this, that maybe it does make sense to take height into consideration. A short person with a 40-inch versus a really tall person with a 40-inch waist, that, to me, seems like it could be different.
Holly Wyatt:
I agree. I think we would need data to show that, though.
James Hill:
Yeah, exactly.
Holly Wyatt:
You know, what is the true risk? What does it lead to? And then does it lead to longer time?
James Hill:
So maybe just a simple weight cutoff may not be the optimum way of doing it.
Holly Wyatt:
Yeah, a waist cutoff. Here's the deal. You can measure your waist. You can measure your height. And you can use either one, right? You can see if you're meeting the criteria of 35 or 40 inches. And then you can also see if you meet the criteria of the 0.5 ratio. So you can look at both and kind of see the difference. And there are some situations where you might fall into the category of high risk for one and not for the other.
James Hill:
Right.
Holly Wyatt:
So before we talk about what they found, how did they measure waist circumference? This is a question I get all the time.
James Hill:
Oh, my gosh.
Holly Wyatt:
Do I measure the belly button? Do I measure it? Is it the smallest? What do I do? How do I measure waist circumference?
James Hill:
And people come in all different shapes. So it is tough sometimes to know exactly where the waist is. And you can't go by belt size or pant size, right?
Holly Wyatt:
I've told you that a lot because, you know, people will buy, and I'm going to say men especially.
James Hill:
Men like to wear their pants lower, below their belly.
Holly Wyatt:
So they have this, you know.
James Hill:
They may be underestimating what their real waist is.
Holly Wyatt:
They'll say, I've got a 38-inch pant, and then kind of look and see what's hanging over the edge of that pant would be a little bit different than 38 inches. So, yeah, don't use your pants. The way that they measured it in this study is they used anatomical kind of I would say, ways to kind of identify where to measure. And I like that, meaning I like it when you use bones or some kind of landmark that you can for sure find again, and it's very clear what you're using. So they measured waist between the lowest rib that you could palpate and the top of the hip bone. And halfway between the two is where they measured waist. So you could push on the lowest rib you have on your side, and you could push on the top of your hip bone, and then you could measure between the two, and then you could divide that by height.
James Hill:
That's a pretty good way of doing it to make sure that everybody's measuring it the same way.
Holly Wyatt:
Yeah, and that's what they did in the study. For my patients, I think the easier way, because sometimes I don't know about me, my lowest rib sits on top, basically. I have no waist or no very much room between there. So another way that is acceptable to do it is just to use the highest part of your hip bone. So to use that just to be able to palpate the highest part of your hip bone and to use that. I think either one is acceptable. But don't use like the belly button. That shifts. That changes. I like bony landmarks. I think that that can be really helpful.
James Hill:
So can people do this at home fairly easily and measure their own waist?
Holly Wyatt:
Yes. And I think when you use that one landmark, it's easier than trying to measure halfway between the two. So I think at home, sometimes just using that higher part of the hip all the way around can be a little bit easier.
James Hill:
So if people measure their waist and measure their height and they do this ratio, they're looking at whether that ratio is higher or lower than 0.5.
Holly Wyatt:
Yes. So is their waist greater than half their height?
James Hill:
And greater than 0.5 would suggest that they're carrying maybe a little extra fat centrally.
Holly Wyatt:
Yes, yes.
James Hill:
Okay, got it. Now, what did they find? We've gotten the measurement out of the way. Were you surprised at some of the findings?
Holly Wyatt:
I was surprised. I really was. First, we'll say that 42% in this group had central obesity across all BMIs, so some elevated BMI's.
James Hill:
So above 0.5 ratio, 42%.
Holly Wyatt:
Yes, and looking at all BMIs, 42% had this elevated waist ratio, regardless, looking at all the BMIs. So that was interesting.
James Hill:
Yeah, but not too surprising. What happened when they looked at central obesity in people with a normal BMI?
Holly Wyatt:
Yeah, so it came out that almost 19%, that was where we kind of got that one in five. 19% had a normal BMI, but this elevated, what they're calling central obesity, this elevated ratio.
James Hill:
So if we were just looking at BMI, we would say, “You guys are fine. You got a normal BMI, don't worry.” But now we're saying there are some people with a normal BMI who maybe should worry a little bit more if they have this high waist to height ratio.
Holly Wyatt:
Almost 20%, Jim. I mean, it's not like a tiny. I mean, 20% to me.
James Hill:
That’s significant. That's not rare.
Holly Wyatt:
We're approaching the 20%. That, to me, you got to pay attention to.
James Hill:
All right. Second question for you. In those people with normal BMI, and a high waist to height ratio, was there any indication that they were actually metabolically different from people with normal BMI and a lower waist to height ratio?
Holly Wyatt:
Yes. And that's what this paper looked at. They saw that compared with normal BMI without central obesity, they had higher odds of hypertension, diabetes, elevated total cholesterol. These were relative odds, not absolute risk. And obviously, this is an association study, but still, Jim, I think we're seeing potentially a signal there.
James Hill:
This is actually pretty amazing because it suggests that maybe 20 percent of the people that we've been saying you're fine, maybe aren't fine. Maybe they need a little treatment.
Holly Wyatt:
Yeah.
James Hill:
That's a lot.
Holly Wyatt:
That's a lot. And while we don't know necessarily how this translates long term, I think it's enough of a signal we should pay attention to and at least look at the individual a little closer.
James Hill:
So, Holly, do you think this means we should just forget BMI? It's not useful?
Holly Wyatt:
No, no, not at all. I think BMI is useful, but it just doesn't tell the whole story.
James Hill:
It's an and, not an or.
Holly Wyatt:
Exactly. Looking at that waist and looking at it compared to how tall you are, I think we maybe need to be looking at that even a little bit more, and especially in young people. Like, this was a young cohort here.
James Hill:
Did they see any difference based on age? Do we know that if older people were worse than younger people?
Holly Wyatt:
Well, I think this study was young adults. Now, I don't know if they could have pulled that.
James Hill:
So, it wasn't enough of a difference probably. But it would be interesting to look at this in older adults as well. Maybe you see more. I don't know. But it'd be interesting.
Holly Wyatt:
Well, I think what we know is a lot of times people tend to gain weight over time. We don't see the drift of people losing weight. Maybe the new GLP-1s will change that trend. But if you start out with this when you're 20 years old, the likelihood of it getting worse, I think, is there. Most people don't improve over time. If anything, they drift the other direction.
James Hill:
Holly, this seems to me like this is a fairly important paper. Really, it kind of fits with where you and I have been going in the last few podcasts, really saying that the scale is not sufficient. And now we're saying BMI is not sufficient. There are other aspects that we need to look at because people are different, same BMI, different, same weight, different. So we need to get away from just looking at risks based on some weight measurement.
Holly Wyatt:
Agree. And while I think this paper, I was surprised, and that's why I wanted to kind of talk about it on the podcast, there was definitely some limitations to it. It was cross-sectional. It used kind of thresholds, not necessarily diagnostic criteria. We can't infer causality or generalize this to older adults. So I always want people to recognize the limits of the paper.
James Hill:
I get it. But what it says is we have an issue that maybe was underappreciated. And that's the fact that a lot of people who are in the normal BMI range may have an elevated metabolic risk due to where their fat is located.
Holly Wyatt:
Agree. And the other thing I like is you can figure this out today. You don't even have to go to your doctor's office.
James Hill:
You can do it at home. Listeners, you can do it and know that.
James Hill:
All right. Now, the big deal is what do we do about it? So, right now, GLP-1s are based on BMI. So, technically, these people with a normal BMI and a high waist-to-height ratio would not qualify for a GLP-1 medication.
Holly Wyatt:
Exactly. The indications for GLP-1 medications are based on BMI and if you have what we call a comorbidity. So let's just make sure everybody knows currently, if you have a body mass index greater than 30, that's an indication for the new weight management drugs. Or if your BMI is greater than 27, that's in the overweight category, with a weight-related comorbidity, you can be put on a medication. But if your BMI is 23, you don't fall into either one of those categories.
James Hill:
Well, do you think, Holly, that, you know, you had said people with the high waist-to-height ratios tend to have hypertension, elevated lipids. Is that capturing it? So would these people qualify based on normal BMI but risk factors? My guess is some might, but there probably are some that haven't expressed those yet that would be at higher risk.
Holly Wyatt:
Right. So you're right. You might get some of them from that.
James Hill:
But we're still going to miss some that could benefit from treatment.
Holly Wyatt:
Well, no, because the indication is BMI greater than 27 and a comorbidity. These people could have BMI of 23 or 24 and a comorbidity. So they really wouldn't be.
James Hill:
Interesting. Okay.
Holly Wyatt:
Yeah. So the waist to height ratio is not an FDA approved indication.
James Hill:
So right now, any measures of waist don't come into criteria for GLP-1 use or any medication use.
Holly Wyatt:
We've talked about it, and we have these criteria of 35 inches and 40 inches, but we really don't use it.
James Hill:
So where do you think, where should we go with this? Is this important enough to rethink the criteria for medication use?
Holly Wyatt:
I think there's an evidence gap looking specifically at normal BMI and central obesity. So that probably needs to be studied. And then we have to think about what outcomes. Because then it's not about decreasing your weight. It's about decreasing your waist.
James Hill:
So you and I know it takes a long, long time to change any of these criteria.
James Hill:
What do we tell people that right now are listening to this? They measured their waist to height ratio and it's high. What do they do?
Holly Wyatt:
Yeah, that's a hard one. I would definitely be looking at some other things. I would definitely want to know what my blood pressure is and my glucose, my family history, all these things, that would alert me that I may carry my fat in a way that could have a negative health outcome independent of my weight without my weight being in that higher category.
James Hill:
So even though they're at a normal weight, is losing a little weight something that might be useful?
Holly Wyatt:
I don't think we know that.
James Hill:
Wow. So right now, they're stuck. There's not really a treatment.
Holly Wyatt:
Well, I think people are going to start studying this group a little bit more, especially with the GLP-1s. They're studying other outcomes for GLP-1s.
James Hill:
What about my favorite, exercise? Can exercise play a role? I'm trying to think of people listening saying, they're saying, it's high. What can I do?
Holly Wyatt:
Oh, I definitely think you can try to probably lose a little bit of weight. It's hard, though, because you don't necessarily need to lose a lot of weight.
James Hill:
It's hard. That's right.
Holly Wyatt:
And measure that waist circumference. Well, what do you think about physical activity and visceral obesity?
James Hill:
Well, you know, I love physical activity, but I don't know. I don't know if these lifestyle changes in people who have a normal weight are going to make a difference. In people that are overweight, I think yes, because it also produces some weight loss. Fascinating question. And actually, I would love to see some research on that. Maybe this paper will highlight this group and people will start doing research on this group. Is weight loss, is exercise, is improving diet helpful in this group, even though they don't need to lose weight?
Holly Wyatt:
Yeah. I think now... For the listeners, recognizing this in yourself and maybe talking to your health care provider about it, because it's not simple. It's not just simply you should do this or you should not do that.
James Hill:
But I want to push back a little bit. So say I'm in that situation. I go to my primary care doc. What do you think they're going to tell me?
Holly Wyatt:
Well, I don't know. It depends on your primary care doc, Jim.
James Hill:
But what, I mean, what options do they have?
Holly Wyatt:
You can still do lifestyle and see.
James Hill:
And we don't know that that works, but it's a good try. So one of the things I'm getting at.
Holly Wyatt:
Okay, here you go. Now I'm going to push back on you.
James Hill:
All right.
Holly Wyatt:
Because let's say you don't lose any weight. Let's take the GLP ones off the table. But you are more physically active. Does that improve your metabolic health?
James Hill:
I think it does. I think it does improve your metabolic health. Again, we don't have any research in this group. But if I had to bet on one lifestyle change, I would bet on physical activity.
Holly Wyatt:
Okay.
James Hill:
But we need some data.
Holly Wyatt:
Okay. So maybe if you see that you have this waist to height risk factor, perhaps are carrying too much belly fat, then maybe lifestyle becomes more important because of that.
James Hill:
Well, I would try it. I would definitely try it. I would try exercise. I would try some resistance training. Things like sleep. We know sleep is terribly important. Those are the things, even though we don't have the data, if I were in that situation, I would try those things.
Holly Wyatt:
Yeah, set yourself up for success. Do those things.
James Hill:
But here's the other thing, Holly, and I am working on a podcast on this. What about GLP-1 use in normal weight people? Is that something that we're going to see more of?We know that these medications do more than lose weight: cardiovascular health, kidney health, maybe arthritis. Are we going to see these things used in other ways than simply obesity treatment?
Holly Wyatt:
I do think that's the direction we're headed, slowly but headed. But then to me, the question is, well, then how do you keep them from losing weight?
James Hill:
And is that going to be a negative or a positive? I don't know. Somebody of a BMI of 23 doesn't need to lose weight. There could be negatives.
Holly Wyatt:
Or someone of the BMI of 21 that actually really doesn't need to lose weight but has another indication that the GLP-1 might help them from an inflammatory standpoint or something else that is proven independent of weight, how do you use that medication in that way without putting them maybe in an unhealthy weight range?
James Hill:
Wow. Boy, there's so much we don't know here. I hope that this study generates some research on this population. 20%, perhaps, of the population that right now has a metabolic problem with no obvious treatment.
Holly Wyatt:
Right. And they're young adults.
James Hill:
And they're young adults. And it's likely going to get worse, which is why I'd like to see this study done in older adults, because I suspect it might even be worse, might even be a higher percent.
Holly Wyatt:
It could even be a higher percent, but I think this is kind of showing where this group is going and should we intervene.
James Hill:
Absolutely.
Holly Wyatt:
Let's do a little pie on the plate. What should we do about it? You know, we like to kind of translate. So we've talked about this study that we're not sure how to use, but what can our listeners do about it?
James Hill:
Well, again, the first thing I would try is exercise. I think it's likely going to give you bang for the buck. We don't have data to be sure of that. There's no downside to exercise. It does a lot of other things. I would try that. Then I would try making sure you get adequate sleep. And third, I would look at nutrition.
Holly Wyatt:
Yeah.
James Hill:
I mean, those are the same things we talk about over and over, but maybe what it does in this population is give them a little bit motivation to change that. Because if you're at normal weight and everything's going fine, you're sort of saying, I'm not worried about this. Everything's going great. Maybe if this ratio is high, maybe it gives you a little motivation to say, everything is not right. Maybe I need to reconnect with some lifestyle factors.
Holly Wyatt:
Agreed. And even before maybe you get to that point, I would say this kind of pushes us to say, look at a more complete health report card. I think we've used that in a couple of our podcasts, looking at more than just one thing. So add waist circumference and this ratio to blood pressure and cholesterol and glucose and your BMI and aerobic fitness and your strength, your physical activity, sleep, nutrition, putting it all together. Almost like we need this report card that we can look at everything in one place and make a decision.
James Hill:
I think that's where we're going. It's a comprehensive approach. we focused for so many years on just weight. And now we're understanding weight is only one of many factors we need to look at. So I like that a comprehensive and not just a metabolic report card, a social happiness report card, an overall quality of life, metabolic health. We're thinking more broadly than just weight.
Holly Wyatt:
Yeah. And include waist. Waist is now going to be a part of that. So I would really challenge the listeners to get out their tape measure and measure their waist, how we just talked about it. You know your height, although I think my height is decreasing, which always makes sense.
James Hill:
I know, that's sad. As you get older, you shrink a little.
Holly Wyatt:
But you can measure your height. Measure your waist. You may even want to do this in some of your family members and just get this data point.
James Hill:
Take your tape measure to the next family get-together and go around and check everybody.
Holly Wyatt:
Yeah, I don't know. Should we recommend they do that at Thanksgiving? I don't think so.
James Hill:
No.
Holly Wyatt:
No, I think it's probably a personal thing.
James Hill:
All right, Holly, you want to do some listener questions?
Holly Wyatt:
Sure. Let's do some listener questions.
James Hill:
All right, I'll do one. “My BMI is normal, but my waist is more than half my height. Am I unhealthy?” Well, not necessarily, but I think this is a time to reconsider that you may want to think about doing something differently. It's not a diagnosis. What it is, it's sort of a caution flag to say, hey, my weight was fine. I thought everything is fine. Now I might have a little bit too much central fat. So I need to think about maybe upping the lifestyle sorts of things. So it's definitely not a diagnosis, but it's maybe a warning system that you might not be totally as healthy as you thought you were.
Holly Wyatt:
This brings me back to what I used to always say. There's three things I used to always think of immediately. What someone's body mass index tells us perhaps that they have too much fat, their waist circumference. I may have too much fat in an area that we think is associated with a poor metabolic outcomes. And that's the third thing, Jim. Do you know what else? Am I gaining weight? What's my...
James Hill:
Oh, yeah. That's the other thing. But many, many people are in a gradual weight gain scenario. So that's a good one.
Holly Wyatt:
Yeah. So I would add that to that.
James Hill:
All right. You want to do one?
Holly Wyatt:
Yeah. So let's see. This is about GLP-1s. “Could I qualify for a GLP-1 if my BMI is normal, but I have a large waist circumference for a large belly fat.” Not now, not under the BMI-based USA weight management indications. We talked about this in the show. Waist size alone doesn't get you there. But I would encourage you to look at the complete picture and talk to your clinician about it. But currently, no, that's not an indication.
James Hill:
All right, I'll do one more. “My scale hasn't moved, but my waist is smaller. Does that count as progress?”
Holly Wyatt:
I'm glad you got that.
James Hill:
It very well could because, again, that would reduce your waist-to-height ratio. And this could be an improvement, especially if you've tried some things to do that, like increasing your strength and fitness and so forth. So that's a great question because a decrease in waist without an overall increase in weight could suggest that you're reducing some of that central obesity.
Holly Wyatt:
Right. I don't know how often that happens. But if it does, and I have had people who've told me that, my waist in my jeans is loose, but the scale hasn't changed.
James Hill:
Usually the scale goes down a little too. But I think in general, a decrease in waist circumference might be a positive move.
Holly Wyatt:
Okay.
James Hill:
You want to do rapid fire or it's just you and I?
Holly Wyatt:
Let's alternate. I'm going to give one to you first.
James Hill:
Okay.
Holly Wyatt:
Can you be metabolically unhealthy at a normal BMI?
James Hill:
Absolutely. That's what the whole show is about today, that a normal BMI doesn't guarantee that metabolically everything will be fine. But a larger waist doesn't automatically mean somebody's metabolically unhealthy either. So it's not an either or. It's an and. BMI and waist.
Holly Wyatt:
Okay.
James Hill:
All right, Holly, what's the bigger mistake, treating someone who doesn't need treatment or missing someone who does?
Holly Wyatt:
Ooh. Jim.
James Hill:
Ooh.
Holly Wyatt:
Both are, both can cause harm. Absolutely. So if you miss a disease and delay your care, that's not good. But unnecessary treatment will expose someone to increase risks without a benefit. That's not good. So I'm not going to answer that. I think both of those you need to avoid for obvious, for those reasons.
James Hill:
Good dodge, Holly.
Holly Wyatt:
I know, I had to. All right, for you, would you rather see a patient lose 10 pounds without improving their metabolic markers, or stay the same weight and significantly improve their metabolic health?
James Hill:
Oh, definitely improve metabolic health. Weight loss can have benefits, but the ultimate goal is better health, not necessarily a number on the scale. All right, Holly, prediction time. Will waist-to-height ratio ever become as familiar as BMI?
Holly Wyatt:
Maybe, but I don't see that happening in the next few years, so not soon. BMI is what we use in clinical practice. It'll take some time before we have enough data to know what to do with it and how to use it, but I think it could at some point. All right, Jim, should someone with a normal BMI but significant metabolic risk ever qualify for a GLP-1 medication? Ooh, hard one for you.
James Hill:
No, this is an easy one. Currently, no, but I think in the future, absolutely. My prediction is that in the not-too-distant future, we will use these GLP-1 medications in this population. But I emphasize, Holly, currently, the guidelines do not include this population.
Holly Wyatt:
All right. And I know it's my turn, but I'm going to do this one to you, Jim, because I want you to answer this one. Can you exercise your way to losing fat specifically from your belly?
James Hill:
Well, unfortunately, no. You can't target specific areas with exercise. But exercise can reduce overall fat. There's some evidence that people with high belly fat may lose some of that early on. So you can't specifically target where the fat comes from. You can target overall fat. And in most cases, a fair amount of that will come from belly fat.
Holly Wyatt:
Yeah, you can't target it. But when we look at the data, it tends to be a place you lose it from. So that's good news.
Holly Wyatt:
All right, vulnerability. Are you ready? I got a good one for you.
James Hill:
I'm ready.
Holly Wyatt:
All right. If we measured your waist-to-height ratio today, would you be nervous about the result?
James Hill:
Hang on.
Holly Wyatt:
Are you doing it?
James Hill:
Yep.
Holly Wyatt:
Do you know what your waist is?
James Hill:
Yep.
Holly Wyatt:
Not your pants size, Jim.
James Hill:
I know.
Holly Wyatt:
Okay. Just making sure.
James Hill:
0.46.
Holly Wyatt:
Ooh. Should we round up?
James Hill:
No. I'm just under.
Holly Wyatt:
You're just under!
James Hill:
Yeah.
Holly Wyatt:
Ooh. Hey.
James Hill:
I don't want to gain any more fat.
Holly Wyatt:
You don't want to gain any more in your waist, for sure, right? Because that would take it over. All right, love it.
James Hill:
All right, Holly, if your BMI was normal, but your waist-to-height ratio suggested increased risk, would you consider taking a GLP-1 medication?
Holly Wyatt:
I would.
James Hill:
Okay.
Holly Wyatt:
I probably would. Now, it's not indicated for that, but would I consider it? I would. I also have a very strong family history of hypertension, heart disease. My dad died very young of a heart attack. I'm on blood pressure pills. So I even would have more data than just that that might push me into trying to see if I could get on a GLP-1, even though that's not the current indication. So it's being vulnerable, just telling the truth.
James Hill:
All right, let's put the pie on the plate. Can we come up with three big things we want people to remember? You go first.
Holly Wyatt:
Okay, let's see. Two people can have the same height, the same weight, which gives them the same BMI, and still have different health risks. BMI is useful, but it doesn't tell us where the fat is carried or doesn't tell us the whole metabolic picture. You need more.
James Hill:
Good. All right. I would say don't trade one magic number for another. Don't say, forget BMI, let's look at waist. Both are important. A waist measurement can add important clues to BMI, but blood pressure, cholesterol, glucose fitness, your overall health matter too.
Holly Wyatt:
Right. I don't want people to think, oh, I'm just going to get rid of BMI and just look at waist. No, it's the whole picture. And third, I would say the next step isn't automatically to lose more weight or even to start a GLP-1, even though we talked a lot about that. It's to understand your individual risk and choose the right actions and the potentially right treatments for you. A normal BMI with a larger waist is a reason, I think, to ask better questions, maybe to get some better measurements. Not necessarily to start on a GLP-1 but to go to your physician, to ask some questions. Perhaps to change your lifestyle, getting a bigger picture.
James Hill:
Okay, so the scale isn't wrong. It's just asking a smaller question than we need to ask. How about that?
Holly Wyatt:
Or answering a smaller question.
James Hill:
Yeah, answering a smaller question. You're right.
Holly Wyatt:
Asking and answering maybe in a way. Yeah, so the goal isn't simply to get a normal BMI. The goal is to get healthier. And I think we need more than one number to help us know if we're getting there.
James Hill:
Yeah, and we featured a study that we think is a very, very important study, but some limitations. It's observational, limited in age, and doesn't evaluate GLP-1 treatment. But it really raises some questions that we hope researchers will follow up on. We need to learn more about this population with a high waist-to-height ratio, but a normal BMI. Okay?
Holly Wyatt:
Exactly. All right.
James Hill:
Thanks, everybody. See you next time on Weight Loss And.
Holly Wyatt:
Bye.
James Hill:
And that's a wrap for today's episode of Weight Loss And. We hope you enjoy diving into the world of weight loss with us.
Holly Wyatt:
If you want to stay connected and continue exploring the “Ands” of weight loss, be sure to follow our podcast on your favorite platform.
James Hill:
We'd also love to hear from you. Share your thoughts, questions, or topic suggestions by reaching out at weightlossand.com. Your feedback helps us tailor future episodes to your needs.
Holly Wyatt:
And remember, the journey doesn't end here. Keep applying the knowledge and strategies you've learned and embrace the power of the “And” in your own weight loss journey.
Apple Podcasts
Spotify
PocketCasts
Castbox
Amazon Music
Podchaser
RSS Feed